Apologies if this has been posted elsewhere.
The "Pridgen" 2b study on IMC-1 for Fibromyalgia has released the initial top-line results and a summary can be found here: https://www.bloomberg.com/press-rel...-from-phase-2b-study-of-imc-1-in-fibromyalgia.
Unfortunately for all of us yet again; it didn't go as well as hoped
.
No real statistical difference in pain alleviation between IMC-1 and placebo.
They will look a little deeper into a possible reduction in expected effectiveness due to certain circumstances but generally speaking, it appears dead in the water
The "Pridgen" 2b study on IMC-1 for Fibromyalgia has released the initial top-line results and a summary can be found here: https://www.bloomberg.com/press-rel...-from-phase-2b-study-of-imc-1-in-fibromyalgia.
Unfortunately for all of us yet again; it didn't go as well as hoped
.No real statistical difference in pain alleviation between IMC-1 and placebo.
They will look a little deeper into a possible reduction in expected effectiveness due to certain circumstances but generally speaking, it appears dead in the water
Last edited:
